Skip NavigationSkip to Content

Structure-based discovery of a boronic acid bioisostere of combretastatin A-4

  1. Author:
    Kong, Y.
    Grembecka, J.
    Edler, M. C.
    Hamel, E.
    Mooberry, S. L.
    Sabat, M.
    Rieger, J.
    Brown, M. L.
  2. Author Address

    Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA. Univ Virginia, Charlottesville, VA 22908 USA. NCI, Div Canc Treatment & Diag, Dev Therapeut Program, Screening Technol Branch,NIH, Frederick, MD 21702 USA. SW Fdn Biomed Res, Dept Physiol & Med, San Antonio, TX 78245 USA Brown, ML, Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA
    1. Year: 2005
    2. Date: SEP
  1. Journal: Chemistry & Biology
    1. 12
    2. 9
    3. Pages: 1007-1014
  2. Type of Article: Article
  1. Abstract:

    Targeting the microtubule system represents an attractive strategy for the development of anticancer agents. In this study, we report a class of combretastatin A-4 (CA-4) analogs derivatized with a boronic acid moiety replacing the hydroxyl group on the C-ring of CA-4. Docking studies of the X-ray structures of our arylboronic analogs onto an X-ray structure of the a, tubulin heterodimer suggested that cis-6 was a potent inhibitor of the colchicine binding. The model indicated that there would be strong hydrogen bonding between the boronic acid moiety and Thr-1 79 and Val-181 of alpha-tubulin. We demonstrate that the cis-6 boronic acid bioisostere of CA-4: (1) inhibits tubulin assembly, (2) competitively displaces colchicine, and (13) is a low-nanomolar inhibitor of human cancer cell lines. We present this isostere as a class of potent analogs of CA-4

    See More

External Sources

  1. DOI: 10.1016/j.chembiol.2005.06.016
  2. WOS: 000232361000011

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel